查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1706756

複合藥房市場； - 2024 年至 2034 年全球產業分析、規模、佔有率、成長、趨勢和預測

Compounding Pharmacy Market; - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 257 Pages | 商品交期: 2-10個工作天內

價格

複合藥房市場 - 報告範圍

TMR 關於全球複合藥房市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。該報告提供了 2018 年至 2034 年期間全球複合藥房市場的收入，以 2024 年為基準年，2034 年為預測年。該報告還提供了 2024 年至 2034 年全球複合藥房市場的年複合成長率(CAGR %)。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解複合藥房市場。

市場概況
2023年市場價值 134.746億美元
2034年的市場價值 268.388億美元
複合年成長率 6.5%

該報告深入探討了全球複合藥房市場的競爭格局。我們已經確定了在全球複合藥房市場中營運的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球複合藥房市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年全球市場分析與預測

第5章：關鍵見解

  • 促進藥物複合的技術進步
  • 關於內部和外包藥物配製的見解
  • 藥物配製的益處和潛在風險的討論
  • 重點地區/國家配藥藥房列表
  • 主要地區/國家的監管情況
  • 波特五力分析
  • PESTEL分析
  • 價值鏈分析
  • 新市場進入者的市場進入策略
  • 重要產業活動

第6章：全球市場分析與預測：依藥局類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年藥局類型市場價值預測
    • 503A藥房
    • 503B藥房
  • 藥局類型的市場吸引力

第7章：全球市場分析與預測：依複合類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年複合型型市場價值預測
    • 藥物成分變更（PIA）
    • 藥品短缺製造
    • 藥物劑量改變（PDA）
  • 按複合類型分類的市場吸引力

第8章：全球市場分析與預測：按無菌性

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年不孕症市場價值預測
    • 無菌
    • 非無菌
  • 不孕性市場吸引力

第9章：全球市場分析與預測：按劑型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年按劑型分類的市場價值預測
    • 口服藥物
      • 膠囊
      • 平板電腦
      • 暫停
      • 其他（咀嚼片等）
    • 外用藥物
      • 乳霜
      • 凝膠
      • 軟膏
      • 其他（貼等）
    • 注射劑
    • 栓劑
    • 其他
  • 不同劑型的市場吸引力

第10章：全球市場分析與預測：按應用

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年各應用市場價值預測
    • 荷爾蒙替代療法
    • 疼痛管理
    • 神經病學
    • 皮膚科
    • 眼科
    • 營養補充品
    • 其他（耳鼻喉科、甲狀腺疾病等）
  • 按應用分類的市場吸引力

第 11 章：全球市場分析與預測：按患者人口統計

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2034 年按患者人口統計資料分類的市場價值預測
    • 人類
      • 兒科
      • 成人
      • 老年
    • 獸醫
  • 按患者人口統計數據分類的市場吸引力

第12章：全球市場分析及預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各國家/地區市場吸引力

第13章：北美市場分析與預測

  • 美國
  • 加拿大

第14章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區

第15章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 澳洲和紐西蘭
  • 亞太其他地區

第16章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 17 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 18 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2023 年）
  • 公司簡介
    • B. Braun SE
    • WEDGEWOOD PHARMACY
    • Fagron
    • Fresenius Kabi AG
    • Avella Specialty Pharmacy
    • Aurora Health Care
    • Walgreen Co.
    • Formul8
    • Triangle Compounding
    • Apollo Clinical Pharmacy
    • The London Specialist Pharmacy Ltd
    • Olympia Pharmacy
    • Fusion Apothecary
    • Albertsons Companies, Inc.
    • JL Diekman and AQ Touchard
    • Roseway Labs
    • Hill's and Milford Pharmacy
    • Other Prominent Players
Product Code: TMRGL86466

Compounding Pharmacy Market - Scope of Report

TMR's report on the global compounding pharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global compounding pharmacy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global compounding pharmacy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the compounding pharmacy market.

Market Snapshot
Market Value in 2023US$ 13474.6 Mn
Market Value in 2034US$ 26838.8 Mn
CAGR6.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global compounding pharmacy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global compounding pharmacy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global compounding pharmacy market.

The report delves into the competitive landscape of the global compounding pharmacy market. Key players operating in the global compounding pharmacy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global compounding pharmacy market profiled in this report.

Key Questions Answered in Global compounding pharmacy Market Report:

  • What is the sales/revenue generated by compounding pharmacy across all regions during the forecast period?
  • What are the opportunities in the global compounding pharmacy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Compounding Pharmacy Market - Research Objectives and Research Approach

The comprehensive report on the global compounding pharmacy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global compounding pharmacy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global compounding pharmacy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Compounding Pharmacy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Compounding Pharmacy Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements that assist Pharmaceutical Compounding
  • 5.2. Insights on In-house and Outsourced Pharmaceutical Compounding
  • 5.3. Discussion on Benefits and Potential Risks of Pharmaceutical Compounding
  • 5.4. List of Compounding Pharmacies across Key Region / Countries
  • 5.5. Regulatory Scenario across Key Regions / Countries
  • 5.6. PORTER's Five Forces Analysis
  • 5.7. PESTEL Analysis
  • 5.8. Value Chain Analysis
  • 5.9. Go-to-Market Strategy for New Market Entrants
  • 5.10. Key Industry Events

6. Global Compounding Pharmacy Market Analysis and Forecasts, By Pharmacy Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Pharmacy Type, 2020-2034
    • 6.3.1. 503A Pharmacies
    • 6.3.2. 503B Pharmacies
  • 6.4. Market Attractiveness By Pharmacy Type

7. Global Compounding Pharmacy Market Analysis and Forecasts, By Compounding Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Compounding Type, 2020-2034
    • 7.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 7.3.2. Drug Shortage Manufacturing
    • 7.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 7.4. Market Attractiveness By Compounding Type

8. Global Compounding Pharmacy Market Analysis and Forecasts, By Sterility

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Sterility, 2020-2034
    • 8.3.1. Sterile
    • 8.3.2. Non-sterile
  • 8.4. Market Attractiveness By Sterility

9. Global Compounding Pharmacy Market Analysis and Forecasts, By Dosage Form

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Dosage Form, 2020-2034
    • 9.3.1. Oral Medications
      • 9.3.1.1. Capsules
      • 9.3.1.2. Tablets
      • 9.3.1.3. Suspensions
      • 9.3.1.4. Others (Chewables, etc.)
    • 9.3.2. Topical Medications
      • 9.3.2.1. Creams
      • 9.3.2.2. Gels
      • 9.3.2.3. Ointments
      • 9.3.2.4. Others (Paste, etc.)
    • 9.3.3. Injectables
    • 9.3.4. Suppositories
    • 9.3.5. Others
  • 9.4. Market Attractiveness By Dosage Form

10. Global Compounding Pharmacy Market Analysis and Forecasts, By Application

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Application, 2020-2034
    • 10.3.1. Hormone Replacement Therapy
    • 10.3.2. Pain Management
    • 10.3.3. Neurology
    • 10.3.4. Dermatology
    • 10.3.5. Ophthalmology
    • 10.3.6. Nutritional Supplements
    • 10.3.7. Others (ENT, Thyroid Disorders, etc.)
  • 10.4. Market Attractiveness By Application

11. Global Compounding Pharmacy Market Analysis and Forecasts, By Patient Demographics

  • 11.1. Introduction & Definition
  • 11.2. Key Findings / Developments
  • 11.3. Market Value Forecast By Patient Demographics, 2020-2034
    • 11.3.1. Human
      • 11.3.1.1. Pediatric
      • 11.3.1.2. Adult
      • 11.3.1.3. Geriatric
    • 11.3.2. Veterinary
  • 11.4. Market Attractiveness By Patient Demographics

12. Global Compounding Pharmacy Market Analysis and Forecasts, By Region

  • 12.1. Key Findings
  • 12.2. Market Value Forecast By Region
    • 12.2.1. North America
    • 12.2.2. Europe
    • 12.2.3. Asia Pacific
    • 12.2.4. Latin America
    • 12.2.5. Middle East & Africa
  • 12.3. Market Attractiveness By Country/Region

13. North America Compounding Pharmacy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Pharmacy Type, 2020-2034
    • 13.2.1. 503A Pharmacies
    • 13.2.2. 503B Pharmacies
  • 13.3. Market Value Forecast By Compounding Type, 2020-2034
    • 13.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 13.3.2. Drug Shortage Manufacturing
    • 13.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 13.4. Market Value Forecast By Sterility, 2020-2034
    • 13.4.1. Sterile
    • 13.4.2. Non-sterile
  • 13.5. Market Value Forecast By Dosage Form, 2020-2034
    • 13.5.1. Oral Medications
      • 13.5.1.1. Capsules
      • 13.5.1.2. Tablets
      • 13.5.1.3. Suspensions
      • 13.5.1.4. Others (Chewables, etc.)
    • 13.5.2. Topical Medications
      • 13.5.2.1. Creams
      • 13.5.2.2. Gels
      • 13.5.2.3. Ointments
      • 13.5.2.4. Others (Paste, etc.)
    • 13.5.3. Injectables
    • 13.5.4. Suppositories
    • 13.5.5. Others
  • 13.6. Market Value Forecast By Application, 2020-2034
    • 13.6.1. Hormone Replacement Therapy
    • 13.6.2. Pain Management
    • 13.6.3. Neurology
    • 13.6.4. Dermatology
    • 13.6.5. Ophthalmology
    • 13.6.6. Nutritional Supplements
    • 13.6.7. Others (ENT, Thyroid Disorders, etc.)
  • 13.7. Market Value Forecast By Patient Demographics, 2020-2034
    • 13.7.1. Human
      • 13.7.1.1. Pediatric
      • 13.7.1.2. Adult
      • 13.7.1.3. Geriatric
    • 13.7.2. Veterinary
  • 13.8. Market Value Forecast By Country, 2020-2034
    • 13.8.1. U.S.
    • 13.8.2. Canada
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Pharmacy Type
    • 13.9.2. By Compounding Type
    • 13.9.3. By Sterility
    • 13.9.4. By Dosage Form
    • 13.9.5. By Application
    • 13.9.6. By Patient Demographics
    • 13.9.7. By Country

14. Europe Compounding Pharmacy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Pharmacy Type, 2020-2034
    • 14.2.1. 503A Pharmacies
    • 14.2.2. 503B Pharmacies
  • 14.3. Market Value Forecast By Compounding Type, 2020-2034
    • 14.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 14.3.2. Drug Shortage Manufacturing
    • 14.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 14.4. Market Value Forecast By Sterility, 2020-2034
    • 14.4.1. Sterile
    • 14.4.2. Non-sterile
  • 14.5. Market Value Forecast By Dosage Form, 2020-2034
    • 14.5.1. Oral Medications
      • 14.5.1.1. Capsules
      • 14.5.1.2. Tablets
      • 14.5.1.3. Suspensions
      • 14.5.1.4. Others (Chewables, etc.)
    • 14.5.2. Topical Medications
      • 14.5.2.1. Creams
      • 14.5.2.2. Gels
      • 14.5.2.3. Ointments
      • 14.5.2.4. Others (Paste, etc.)
    • 14.5.3. Injectables
    • 14.5.4. Suppositories
    • 14.5.5. Others
  • 14.6. Market Value Forecast By Application, 2020-2034
    • 14.6.1. Hormone Replacement Therapy
    • 14.6.2. Pain Management
    • 14.6.3. Neurology
    • 14.6.4. Dermatology
    • 14.6.5. Ophthalmology
    • 14.6.6. Nutritional Supplements
    • 14.6.7. Others (ENT, Thyroid Disorders, etc.)
  • 14.7. Market Value Forecast By Patient Demographics, 2020-2034
    • 14.7.1. Human
      • 14.7.1.1. Pediatric
      • 14.7.1.2. Adult
      • 14.7.1.3. Geriatric
    • 14.7.2. Veterinary
  • 14.8. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.8.1. Germany
    • 14.8.2. U.K.
    • 14.8.3. France
    • 14.8.4. Italy
    • 14.8.5. Spain
    • 14.8.6. Rest of Europe
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Pharmacy Type
    • 14.9.2. By Compounding Type
    • 14.9.3. By Sterility
    • 14.9.4. By Dosage Form
    • 14.9.5. By Application
    • 14.9.6. By Patient Demographics
    • 14.9.7. By Country/Sub-region

15. Asia Pacific Compounding Pharmacy Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Pharmacy Type, 2020-2034
    • 15.2.1. 503A Pharmacies
    • 15.2.2. 503B Pharmacies
  • 15.3. Market Value Forecast By Compounding Type, 2020-2034
    • 15.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 15.3.2. Drug Shortage Manufacturing
    • 15.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 15.4. Market Value Forecast By Sterility, 2020-2034
    • 15.4.1. Sterile
    • 15.4.2. Non-sterile
  • 15.5. Market Value Forecast By Dosage Form, 2020-2034
    • 15.5.1. Oral Medications
      • 15.5.1.1. Capsules
      • 15.5.1.2. Tablets
      • 15.5.1.3. Suspensions
      • 15.5.1.4. Others (Chewables, etc.)
    • 15.5.2. Topical Medications
      • 15.5.2.1. Creams
      • 15.5.2.2. Gels
      • 15.5.2.3. Ointments
      • 15.5.2.4. Others (Paste, etc.)
    • 15.5.3. Injectables
    • 15.5.4. Suppositories
    • 15.5.5. Others
  • 15.6. Market Value Forecast By Application, 2020-2034
    • 15.6.1. Hormone Replacement Therapy
    • 15.6.2. Pain Management
    • 15.6.3. Neurology
    • 15.6.4. Dermatology
    • 15.6.5. Ophthalmology
    • 15.6.6. Sports Medicine
    • 15.6.7. Nutritional Supplements
    • 15.6.8. Others (ENT, Thyroid Disorders, etc.)
  • 15.7. Market Value Forecast By Patient Demographics, 2020-2034
    • 15.7.1. Human
      • 15.7.1.1. Pediatric
      • 15.7.1.2. Adult
      • 15.7.1.3. Geriatric
    • 15.7.2. Veterinary
  • 15.8. Market Value Forecast By Country/Sub-region, 2020-2034
    • 15.8.1. China
    • 15.8.2. India
    • 15.8.3. Japan
    • 15.8.4. Australia & New Zealand
    • 15.8.5. Rest of Asia Pacific
  • 15.9. Market Attractiveness Analysis
    • 15.9.1. By Pharmacy Type
    • 15.9.2. By Compounding Type
    • 15.9.3. By Sterility
    • 15.9.4. By Dosage Form
    • 15.9.5. By Application
    • 15.9.6. By Patient Demographics
    • 15.9.7. By Country/Sub-region

16. Latin America Compounding Pharmacy Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Pharmacy Type, 2020-2034
    • 16.2.1. 503A Pharmacies
    • 16.2.2. 503B Pharmacies
  • 16.3. Market Value Forecast By Compounding Type, 2020-2034
    • 16.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 16.3.2. Drug Shortage Manufacturing
    • 16.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 16.4. Market Value Forecast By Sterility, 2020-2034
    • 16.4.1. Sterile
    • 16.4.2. Non-sterile
  • 16.5. Market Value Forecast By Dosage Form, 2020-2034
    • 16.5.1. Oral Medications
      • 16.5.1.1. Capsules
      • 16.5.1.2. Tablets
      • 16.5.1.3. Suspensions
      • 16.5.1.4. Others (Chewables, etc.)
    • 16.5.2. Topical Medications
      • 16.5.2.1. Creams
      • 16.5.2.2. Gels
      • 16.5.2.3. Ointments
      • 16.5.2.4. Others (Paste, etc.)
    • 16.5.3. Injectables
    • 16.5.4. Suppositories
    • 16.5.5. Others
  • 16.6. Market Value Forecast By Application, 2020-2034
    • 16.6.1. Hormone Replacement Therapy
    • 16.6.2. Pain Management
    • 16.6.3. Neurology
    • 16.6.4. Dermatology
    • 16.6.5. Ophthalmology
    • 16.6.6. Nutritional Supplements
    • 16.6.7. Others (ENT, Thyroid Disorders, etc.)
  • 16.7. Market Value Forecast By Patient Demographics, 2020-2034
    • 16.7.1. Human
      • 16.7.1.1. Pediatric
      • 16.7.1.2. Adult
      • 16.7.1.3. Geriatric
    • 16.7.2. Veterinary
  • 16.8. Market Value Forecast By Country/Sub-region, 2020-2034
    • 16.8.1. Brazil
    • 16.8.2. Mexico
    • 16.8.3. Rest of Latin America
  • 16.9. Market Attractiveness Analysis
    • 16.9.1. By Pharmacy Type
    • 16.9.2. By Compounding Type
    • 16.9.3. By Sterility
    • 16.9.4. By Dosage Form
    • 16.9.5. By Application
    • 16.9.6. By Patient Demographics
    • 16.9.7. By Country/Sub-region

17. Middle East & Africa Compounding Pharmacy Market Analysis and Forecast

  • 17.1. Introduction
    • 17.1.1. Key Findings
  • 17.2. Market Value Forecast By Pharmacy Type, 2020-2034
    • 17.2.1. 503A Pharmacies
    • 17.2.2. 503B Pharmacies
  • 17.3. Market Value Forecast By Compounding Type, 2020-2034
    • 17.3.1. Pharmaceutical Ingredient Alteration (PIA)
    • 17.3.2. Drug Shortage Manufacturing
    • 17.3.3. Pharmaceutical Dosage Alteration (PDA)
  • 17.4. Market Value Forecast By Sterility, 2020-2034
    • 17.4.1. Sterile
    • 17.4.2. Non-sterile
  • 17.5. Market Value Forecast By Dosage Form, 2020-2034
    • 17.5.1. Oral Medications
      • 17.5.1.1. Capsules
      • 17.5.1.2. Tablets
      • 17.5.1.3. Suspensions
      • 17.5.1.4. Others (Chewables, etc.)
    • 17.5.2. Topical Medications
      • 17.5.2.1. Creams
      • 17.5.2.2. Gels
      • 17.5.2.3. Ointments
      • 17.5.2.4. Others (Paste, etc.)
    • 17.5.3. Injectables
    • 17.5.4. Suppositories
    • 17.5.5. Others
  • 17.6. Market Value Forecast By Application, 2020-2034
    • 17.6.1. Hormone Replacement Therapy
    • 17.6.2. Pain Management
    • 17.6.3. Neurology
    • 17.6.4. Dermatology
    • 17.6.5. Ophthalmology
    • 17.6.6. Nutritional Supplements
    • 17.6.7. Others (ENT, Thyroid Disorders, etc.)
  • 17.7. Market Value Forecast By Patient Demographics, 2020-2034
    • 17.7.1. Human
      • 17.7.1.1. Pediatric
      • 17.7.1.2. Adult
      • 17.7.1.3. Geriatric
    • 17.7.2. Veterinary
  • 17.8. Market Value Forecast By Country/Sub-region, 2020-2034
    • 17.8.1. GCC Countries
    • 17.8.2. South Africa
    • 17.8.3. Rest of Middle East & Africa
  • 17.9. Market Attractiveness Analysis
    • 17.9.1. By Pharmacy Type
    • 17.9.2. By Compounding Type
    • 17.9.3. By Sterility
    • 17.9.4. By Dosage Form
    • 17.9.5. By Application
    • 17.9.6. By Patient Demographics
    • 17.9.7. By Country/Sub-region

18. Competition Landscape

  • 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 18.2. Market Share Analysis By Company (2023)
  • 18.3. Company Profiles
    • 18.3.1. B. Braun SE
      • 18.3.1.1. Company Overview
      • 18.3.1.2. Financial Overview
      • 18.3.1.3. Financial Overview
      • 18.3.1.4. Business Strategies
      • 18.3.1.5. Recent Developments
    • 18.3.2. WEDGEWOOD PHARMACY
      • 18.3.2.1. Company Overview
      • 18.3.2.2. Financial Overview
      • 18.3.2.3. Financial Overview
      • 18.3.2.4. Business Strategies
      • 18.3.2.5. Recent Developments
    • 18.3.3. Fagron
      • 18.3.3.1. Company Overview
      • 18.3.3.2. Financial Overview
      • 18.3.3.3. Financial Overview
      • 18.3.3.4. Business Strategies
      • 18.3.3.5. Recent Developments
    • 18.3.4. Fresenius Kabi AG
      • 18.3.4.1. Company Overview
      • 18.3.4.2. Financial Overview
      • 18.3.4.3. Financial Overview
      • 18.3.4.4. Business Strategies
      • 18.3.4.5. Recent Developments
    • 18.3.5. Avella Specialty Pharmacy
      • 18.3.5.1. Company Overview
      • 18.3.5.2. Financial Overview
      • 18.3.5.3. Financial Overview
      • 18.3.5.4. Business Strategies
      • 18.3.5.5. Recent Developments
    • 18.3.6. Aurora Health Care
      • 18.3.6.1. Company Overview
      • 18.3.6.2. Financial Overview
      • 18.3.6.3. Financial Overview
      • 18.3.6.4. Business Strategies
      • 18.3.6.5. Recent Developments
    • 18.3.7. Walgreen Co.
      • 18.3.7.1. Company Overview
      • 18.3.7.2. Financial Overview
      • 18.3.7.3. Financial Overview
      • 18.3.7.4. Business Strategies
      • 18.3.7.5. Recent Developments
    • 18.3.8. Formul8
      • 18.3.8.1. Company Overview
      • 18.3.8.2. Financial Overview
      • 18.3.8.3. Financial Overview
      • 18.3.8.4. Business Strategies
      • 18.3.8.5. Recent Developments
    • 18.3.9. Triangle Compounding
      • 18.3.9.1. Company Overview
      • 18.3.9.2. Financial Overview
      • 18.3.9.3. Financial Overview
      • 18.3.9.4. Business Strategies
      • 18.3.9.5. Recent Developments
    • 18.3.10. Apollo Clinical Pharmacy
      • 18.3.10.1. Company Overview
      • 18.3.10.2. Financial Overview
      • 18.3.10.3. Financial Overview
      • 18.3.10.4. Business Strategies
      • 18.3.10.5. Recent Developments
    • 18.3.11. The London Specialist Pharmacy Ltd
      • 18.3.11.1. Company Overview
      • 18.3.11.2. Financial Overview
      • 18.3.11.3. Financial Overview
      • 18.3.11.4. Business Strategies
      • 18.3.11.5. Recent Developments
    • 18.3.12. Olympia Pharmacy
      • 18.3.12.1. Company Overview
      • 18.3.12.2. Financial Overview
      • 18.3.12.3. Financial Overview
      • 18.3.12.4. Business Strategies
      • 18.3.12.5. Recent Developments
    • 18.3.13. Fusion Apothecary
      • 18.3.13.1. Company Overview
      • 18.3.13.2. Financial Overview
      • 18.3.13.3. Financial Overview
      • 18.3.13.4. Business Strategies
      • 18.3.13.5. Recent Developments
    • 18.3.14. Albertsons Companies, Inc.
      • 18.3.14.1. Company Overview
      • 18.3.14.2. Financial Overview
      • 18.3.14.3. Financial Overview
      • 18.3.14.4. Business Strategies
      • 18.3.14.5. Recent Developments
    • 18.3.15. JL Diekman and AQ Touchard
      • 18.3.15.1. Company Overview
      • 18.3.15.2. Financial Overview
      • 18.3.15.3. Financial Overview
      • 18.3.15.4. Business Strategies
      • 18.3.15.5. Recent Developments
    • 18.3.16. Roseway Labs
      • 18.3.16.1. Company Overview
      • 18.3.16.2. Financial Overview
      • 18.3.16.3. Financial Overview
      • 18.3.16.4. Business Strategies
      • 18.3.16.5. Recent Developments
    • 18.3.17. Hill's Compounding Pharmacy and Milford Pharmacy
      • 18.3.17.1. Company Overview
      • 18.3.17.2. Financial Overview
      • 18.3.17.3. Financial Overview
      • 18.3.17.4. Business Strategies
      • 18.3.17.5. Recent Developments
    • 18.3.18. Other Prominent Players
      • 18.3.18.1. Company Overview
      • 18.3.18.2. Financial Overview
      • 18.3.18.3. Financial Overview
      • 18.3.18.4. Business Strategies
      • 18.3.18.5. Recent Developments

List of Tables

  • Table 01: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Pharmacy Type, 2020-2034
  • Table 02: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 03: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 04: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 05: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 06: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 07: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
  • Table 08: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 09: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
  • Table 10: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, By Region, 2020-2034
  • Table 11: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 12: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
  • Table 13: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 14: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 15: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 16: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 17: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 18: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2034
  • Table 19: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 20: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
  • Table 21: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 22: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
  • Table 23: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 24: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 25: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 26: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 27: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 28: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
  • Table 29: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 30: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
  • Table 31: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 32: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
  • Table 33: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 34: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 35: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 36: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 37: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 38: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
  • Table 39: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 40: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
  • Table 41: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 42: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
  • Table 43: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 44: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 45: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 46: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 47: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 48: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
  • Table 49: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 50: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034
  • Table 51: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 52: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, by Pharmacy Type, 2020-2034
  • Table 53: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Compounding Type, 2020-2034
  • Table 54: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Sterility, 2020-2034
  • Table 55: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Dosage Form, 2020-2034
  • Table 56: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Oral Medications, 2020-2034
  • Table 57: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Topical Medications, 2020-2034
  • Table 58: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Application, 2020-2034
  • Table 59: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Patient Demographics, 2020-2034
  • Table 60: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, By Human, 2020-2034

List of Figures

  • Figure 01: Global Compounding Pharmacy Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Figure 02: Global Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 03: Global Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 04: Global Compounding Pharmacy Market Revenue (US$ Mn), by 503A Pharmacies, 2020-2034
  • Figure 05: Global Compounding Pharmacy Market Revenue (US$ Mn), by 503B Pharmacies, 2020-2034
  • Figure 06: Global Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 07: Global Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 08: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pharmaceutical Ingredient Alteration (PIA), 2020-2034
  • Figure 09: Global Compounding Pharmacy Market Revenue (US$ Mn), by Drug Shortage Manufacturing, 2020-2034
  • Figure 10: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pharmaceutical Dosage Alteration (PDA), 2020-2034
  • Figure 11: Global Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 12: Global Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 13: Global Compounding Pharmacy Market Revenue (US$ Mn), by Sterile, 2020-2034
  • Figure 14: Global Compounding Pharmacy Market Revenue (US$ Mn), by Non-sterile, 2020-2034
  • Figure 15: Global Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 16: Global Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 17: Global Compounding Pharmacy Market Revenue (US$ Mn), by Oral Medications, 2020-2034
  • Figure 18: Global Compounding Pharmacy Market Revenue (US$ Mn), by Topical Medications, 2020-2034
  • Figure 19: Global Compounding Pharmacy Market Revenue (US$ Mn), by Injectables, 2020-2034
  • Figure 20: Global Compounding Pharmacy Market Revenue (US$ Mn), by Suppositories, 2020-2034
  • Figure 21: Global Compounding Pharmacy Market Revenue (US$ Mn), by Others, 2020-2034
  • Figure 22: Global Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 23: Global Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 24: Global Compounding Pharmacy Market Revenue (US$ Mn), by Hormone Replacement Therapy, 2020-2034
  • Figure 25: Global Compounding Pharmacy Market Revenue (US$ Mn), by Dermatology & Wound Care, 2020-2034
  • Figure 26: Global Compounding Pharmacy Market Revenue (US$ Mn), by Pain Management, 2020-2034
  • Figure 27: Global Compounding Pharmacy Market Revenue (US$ Mn), by Ophthalmology, 2020-2034
  • Figure 28: Global Compounding Pharmacy Market Revenue (US$ Mn), by Neurology, 2020-2034
  • Figure 29: Global Compounding Pharmacy Market Revenue (US$ Mn), by Nutritional Supplements, 2020-2034
  • Figure 30: Global Compounding Pharmacy Market Revenue (US$ Mn), by Others, 2020-2034
  • Figure 31: Global Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 32: Global Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
  • Figure 33: Global Compounding Pharmacy Market Revenue (US$ Mn), by Human, 2020-2034
  • Figure 34: Global Compounding Pharmacy Market Revenue (US$ Mn), by Veterinary, 2020-2034
  • Figure 35: Global Compounding Pharmacy Market Value Share Analysis, By Region, 2023 and 2034
  • Figure 36: Global Compounding Pharmacy Market Attractiveness Analysis, By Region, 2024-2034
  • Figure 37: North America - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 38: North America - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 39: North America - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 40: North America Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 41: North America Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 42: North America - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 43: North America - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 44: North America - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 45: North America - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 46: North America - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 47: North America - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 48: North America - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 49: North America - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 50: North America - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 51: North America - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
  • Figure 52: Europe - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 53: Europe - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 54: Europe - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 55: Europe Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 56: Europe Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 57: Europe - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 58: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 59: Europe - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 60: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 61: Europe - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 62: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 63: Europe - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 64: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 65: Europe - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 66: Europe - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
  • Figure 67: Asia Pacific - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 68: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 69: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 70: Asia Pacific Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 71: Asia Pacific Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 72: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 73: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 74: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 75: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 76: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 77: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 78: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 79: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 80: Asia Pacific - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 81: Asia Pacific - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
  • Figure 82: Latin America - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 83: Latin America - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 84: Latin America - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 85: Latin America Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 86: Latin America Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 87: Latin America - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 88: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 89: Latin America - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 90: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 91: Latin America - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 92: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 93: Latin America - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 94: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 95: Latin America - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 96: Latin America - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034
  • Figure 97: Middle East and Africa - Compounding Pharmacy Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 98: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 99: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 100: Middle East and Africa Compounding Pharmacy Market Value Share Analysis, By Pharmacy Type, 2023 and 2034
  • Figure 101: Middle East and Africa Compounding Pharmacy Market Attractiveness Analysis, By Pharmacy Type, 2024-2034
  • Figure 102: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Compounding Type, 2023 and 2034
  • Figure 103: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Compounding Type, 2024-2034
  • Figure 104: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Sterility, 2023 and 2034
  • Figure 105: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Sterility, 2024-2034
  • Figure 106: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Dosage Form, 2023 and 2034
  • Figure 107: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Dosage Form, 2024-2034
  • Figure 108: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Application, 2023 and 2034
  • Figure 109: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Application, 2024-2034
  • Figure 110: Middle East and Africa - Compounding Pharmacy Market Value Share Analysis, By Patient Demographics, 2023 and 2034
  • Figure 111: Middle East and Africa - Compounding Pharmacy Market Attractiveness Analysis, By Patient Demographics, 2024-2034